20/20 Onsite’s Post

View organization page for 20/20 Onsite, graphic

2,640 followers

Jeanne Hecht, CEO and Chairwoman of Lexitas Pharma Services and esteemed member of 20/20 Onsite's Industry and Scientific Advisory Board, recently participated in a dynamic panel exploring the latest market trends for CROs. The discussion highlighted key topics such as the importance of specialization, ensuring diversity in clinical trials, and leveraging AI to enhance efficiency. The panel also addressed demands from pharmaceutical companies for expedited and high-quality trials. Congratulations, Jeanne, on your contributions to this important conversation. We look forward to hearing more of your insights and advancements. Dive into the key takeaways from the session:https://hubs.ly/Q02K_1NQ0 #CROs #LifeScience #TA #AI #ClinicalResearch

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics